<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01523132</url>
  </required_header>
  <id_info>
    <org_study_id>H-D-2007-0098</org_study_id>
    <nct_id>NCT01523132</nct_id>
  </id_info>
  <brief_title>Persistent Pain After Breast Cancer Treatment (PPBCT) - Risk Factors and Pathophysiological Mechanisms</brief_title>
  <official_title>Persistent Pain After Breast Cancer Treatment (PPBCT) - Risk Factors and Pathophysiological Mechanisms</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Danish Breast Cancer Cooperative Group</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Danish Cancer Society</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is a prospective cohort study following breast cancer patients from before surgery
      to one year after. The aims of the study are to determine risk factors that predispose to the
      development of persistent pain.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of the study is 1) to determine pre-, intra and post surgical risk factors for
      persistent pain after breast cancer treatment 2) to examine the prevalence of persistent pain
      6 and 12 months after surgery 3) provide a quantitative sensory testing (QST) profile of the
      patient population, measured pre surgery, 1 week and 12 months after surgery.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Actual">November 2014</completion_date>
  <primary_completion_date type="Actual">November 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Risk factors predisposing for persistent pain after breast cancer treatment</measure>
    <time_frame>12 months postoperative</time_frame>
    <description>Pre-, intra- and postoperative risk factors predisposing for persistent pain</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prevalence of persistent pain after breast cancer treatment</measure>
    <time_frame>12 months postoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prevalence of sensory disturbances after breast cancer treatment</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation of persistent pain after breast cancer treatment and damage of the intercostobrachial nerve</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quantitative sensory testing: profile and correlation to persistent pain, sensory disturbances, signs of neuropathic pain, and treatment related factors</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Genetic markers and the development of persistent pain after breast cancer treatment</measure>
    <time_frame>12 months postoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>QST profile 1 week after surgery for breast cancer</measure>
    <time_frame>1 week postoperative</time_frame>
    <description>Detailed QST profile 1 week after surgery for breast cancer. Patients will be assessed with sensory mapping, followed by assessment of mechanical and thermal thresholds.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute pain after surgery for breast cancer</measure>
    <time_frame>1 week postoperative</time_frame>
    <description>Prevalence of acute pain 1 week after surgery for breast cancer.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Test-Retest of QST after breast cancer treatment</measure>
    <time_frame>12 months postoperative</time_frame>
    <description>A test-retest series of a subgroup of patients assessed with QST, to evaluate methodological reliability. Patients are scheduled to 2 QST assessments with a week between.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">545</enrollment>
  <condition>Breast Cancer</condition>
  <condition>Persistent Pain</condition>
  <condition>Lymphedema</condition>
  <condition>Neuropathic Pain</condition>
  <condition>Neuropathy</condition>
  <arm_group>
    <arm_group_label>Breast cancer patients</arm_group_label>
    <description>Female breast cancer patients without metastasis and locally advanced disease</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Breast cancer patients treated in a university hospital
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosed with breast cancer

          -  18 years or older

        Exclusion Criteria:

          -  unable to give written consent

          -  unable to understand Danish

          -  Previous cosmetic surgery in the breast

          -  Previous surgery in ipsilateral breast

          -  Bilateral cancer

          -  Concomitant corrective surgery on contralateral side

          -  Pregnant

          -  Other disease or injury in the nervous system

          -  Psychiatric disease

          -  Alcohol or drug abuse
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kenneth Geving Andersen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rigshospitalet, Denmark</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Henrik Kehlet, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Rigshospitalet, Denmark</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rigshospitalet, Copenhagen University Hospital</name>
      <address>
        <city>Copenhagen</city>
        <zip>DK-2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <reference>
    <citation>Andersen KG, Kehlet H. Persistent pain after breast cancer treatment: a critical review of risk factors and strategies for prevention. J Pain. 2011 Jul;12(7):725-46. doi: 10.1016/j.jpain.2010.12.005. Epub 2011 Mar 24. Review.</citation>
    <PMID>21435953</PMID>
  </reference>
  <results_reference>
    <citation>Andersen KG, Duriaud HM, Jensen HE, Kroman N, Kehlet H. Predictive factors for the development of persistent pain after breast cancer surgery. Pain. 2015 Dec;156(12):2413-22. doi: 10.1097/j.pain.0000000000000298.</citation>
    <PMID>26176893</PMID>
  </results_reference>
  <results_reference>
    <citation>Andersen KG, Kehlet H, Aasvang EK. Test-retest agreement and reliability of quantitative sensory testing 1 year after breast cancer surgery. Clin J Pain. 2015 May;31(5):393-403. doi: 10.1097/AJP.0000000000000136.</citation>
    <PMID>25084072</PMID>
  </results_reference>
  <results_reference>
    <citation>Andersen KG, Duriaud HM, Aasvang EK, Kehlet H. Association between sensory dysfunction and pain 1 week after breast cancer surgery: a psychophysical study. Acta Anaesthesiol Scand. 2016 Feb;60(2):259-69. doi: 10.1111/aas.12641. Epub 2015 Oct 8.</citation>
    <PMID>26446738</PMID>
  </results_reference>
  <results_reference>
    <citation>Andersen KG, Aasvang EK, Kroman N, Kehlet H. Intercostobrachial nerve handling and pain after axillary lymph node dissection for breast cancer. Acta Anaesthesiol Scand. 2014 Nov;58(10):1240-8. doi: 10.1111/aas.12393.</citation>
    <PMID>25307709</PMID>
  </results_reference>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 27, 2012</study_first_submitted>
  <study_first_submitted_qc>January 27, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 1, 2012</study_first_posted>
  <last_update_submitted>April 5, 2016</last_update_submitted>
  <last_update_submitted_qc>April 5, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 6, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Kenneth Geving Andersen</investigator_full_name>
    <investigator_title>Physician, research fellow</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
    <mesh_term>Neuralgia</mesh_term>
    <mesh_term>Lymphedema</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

